• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淀粉样变性与晕厥之谜。

Amyloidosis and the Syncopal Enigma.

作者信息

Strelow Brittany, Middleton Hayden, Young Kathleen A, Olson Nicole, Boucher Lauren, Cera Alanna, Boswell Christopher L

机构信息

Mayo Clinic, Rochester, MN, USA.

M Health Fairview, St. Paul, MN, USA.

出版信息

J Prim Care Community Health. 2024 Jan-Dec;15:21501319241308025. doi: 10.1177/21501319241308025.

DOI:10.1177/21501319241308025
PMID:39676246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11648006/
Abstract

BACKGROUND

Syncope is a common presenting complaint in the outpatient setting and requires a thoughtful and meticulous approach to history-taking skills. This is crucial in discerning cardiac versus non-cardiac etiologies, underscoring the pivotal role of healthcare professionals in the diagnostic process.

CASE REPORT

This is a case of a 76-year-old male who presented to the primary care clinic following an episode of syncope with abrupt loss of consciousness. Given the presentation, there was a high suspicion of cardiac etiology, and further testing was pursued. An electrocardiogram (ECG) demonstrated normal sinus rhythm with a pre-existing first-degree atrioventricular (AV) block. The Holter monitor was without sustained arrhythmias. A dobutamine stress echocardiogram was negative for myocardial ischemia, though a resting transthoracic echocardiogram demonstrated findings consistent with cardiac amyloidosis. Further evaluation with cardiology confirmed the diagnosis of transthyretin (ATTR) cardiac amyloidosis. He was initiated on appropriate treatment and underwent a dual chamber implantable cardioverter defibrillator (ICD) given his presentation. The patient ultimately succumbed to his disease 5 years after his diagnosis.

CONCLUSION

If the cardiac etiology of syncope is suspected, further cardiac structural evaluation is necessary. Cardiac amyloidosis, although rare, is a cause of cardiogenic syncope that should not be overlooked. It should be considered in the differential diagnosis in the appropriate clinical setting, highlighting the need for a broad and comprehensive approach to diagnosis.

摘要

背景

晕厥是门诊常见的就诊主诉,需要采用周全且细致的病史采集技巧。这对于区分心脏性与非心脏性病因至关重要,凸显了医疗保健专业人员在诊断过程中的关键作用。

病例报告

这是一例76岁男性患者,因一次晕厥伴意识突然丧失前来基层医疗诊所就诊。鉴于其临床表现,高度怀疑为心脏病因,并进行了进一步检查。心电图(ECG)显示正常窦性心律,存在既往一度房室(AV)阻滞。动态心电图监测未发现持续性心律失常。多巴酚丁胺负荷超声心动图检查心肌缺血呈阴性,尽管静息经胸超声心动图检查结果与心脏淀粉样变性相符。心内科进一步评估确诊为转甲状腺素蛋白(ATTR)心脏淀粉样变性。鉴于其临床表现,开始给予适当治疗并植入了双腔植入式心脏复律除颤器(ICD)。该患者最终在确诊5年后死于该病。

结论

如果怀疑晕厥的病因是心脏性的,则需要进一步进行心脏结构评估。心脏淀粉样变性虽然罕见,但却是心源性晕厥的一个病因,不应被忽视。在适当的临床环境中,应将其纳入鉴别诊断,这凸显了采用广泛而全面的诊断方法的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b7/11648006/d9743aae8566/10.1177_21501319241308025-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b7/11648006/d9743aae8566/10.1177_21501319241308025-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b7/11648006/d9743aae8566/10.1177_21501319241308025-fig1.jpg

相似文献

1
Amyloidosis and the Syncopal Enigma.淀粉样变性与晕厥之谜。
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241308025. doi: 10.1177/21501319241308025.
2
Cardiac Amyloidosis in a Child Presenting with Syncope: The First Reported Case and a Diagnostic Dilemma.儿童晕厥伴发心肌淀粉样变性:首例报告及诊断难题
Pediatr Cardiol. 2022 Mar;43(3):700-703. doi: 10.1007/s00246-021-02778-9. Epub 2021 Nov 16.
3
Sustained Ventricular Tachycardia as the first presentation of transthyretin amyloid cardiomyopathy.持续性室性心动过速作为转甲状腺素蛋白淀粉样变心肌病的首发表现。
Rev Fac Cien Med Univ Nac Cordoba. 2024 Dec 13;81(4):768-782. doi: 10.31053/1853.0605.v81.n4.44893.
4
Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.心肌ATTR 淀粉样变的诊断和治疗进展。
Heart Fail Rev. 2019 Jul;24(4):521-533. doi: 10.1007/s10741-019-09776-3.
5
"A case of cardiac amyloidosis with syncope".一例伴有晕厥的心脏淀粉样变性病例
Indian Heart J. 2010 Mar-Apr;62(2):171-2.
6
Imaging modalities in cardiac amyloidosis.心脏淀粉样变性的影像学方式。
Curr Probl Cardiol. 2024 Dec;49(12):102858. doi: 10.1016/j.cpcardiol.2024.102858. Epub 2024 Sep 19.
7
Cardiac amyloidosis: updates in diagnosis and management.心脏淀粉样变性:诊断与治疗进展。
Arch Cardiovasc Dis. 2013 Oct;106(10):528-40. doi: 10.1016/j.acvd.2013.06.051. Epub 2013 Sep 23.
8
Prevalence, Incidence, and Impact on Mortality of Conduction System Disease in Transthyretin Cardiac Amyloidosis.转甲状腺素蛋白心脏淀粉样变性患者传导系统疾病的患病率、发病率及其对死亡率的影响。
Am J Cardiol. 2020 Aug 1;128:140-146. doi: 10.1016/j.amjcard.2020.05.021. Epub 2020 May 16.
9
[Clinical case of generalized amyloidosis (ATTR-amyloidosis) with a progressive course of chronic heart failure. Case report].[伴有慢性心力衰竭进行性病程的全身性淀粉样变性(ATTR-淀粉样变性)临床病例。病例报告]
Ter Arkh. 2024 Jul 30;96(7):695-700. doi: 10.26442/00403660.2024.07.202784.
10
Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.由淀粉样前体蛋白转甲状腺素蛋白V122I变体引起的散发性心脏淀粉样变性
Int Heart J. 2019 Nov 30;60(6):1441-1443. doi: 10.1536/ihj.19-134. Epub 2019 Oct 31.

本文引用的文献

1
Two Kinds of Cardiac Amyloidosis in One Patient: A Case Report.一名患者患两种类型的心脏淀粉样变性:病例报告
Acta Cardiol Sin. 2022 Nov;38(6):806-809. doi: 10.6515/ACS.202211_38(6).20220425B.
2
A Review of Cardiac Amyloidosis: Presentation, Diagnosis, and Treatment.心脏淀粉样变性:临床表现、诊断与治疗综述。
Curr Probl Cardiol. 2022 Dec;47(12):101366. doi: 10.1016/j.cpcardiol.2022.101366. Epub 2022 Aug 20.
3
Red flags for the diagnosis of cardiac amyloidosis: simple suggestions to raise suspicion and achieve earlier diagnosis.
诊断心脏淀粉样变性的红色警报:提高警惕并尽早诊断的简单建议。
J Cardiovasc Med (Hagerstown). 2022 Aug 1;23(8):493-504. doi: 10.2459/JCM.0000000000001337.
4
Cardiac Amyloidosis.心脏淀粉样变性。
Heart Fail Clin. 2022 Jul;18(3):479-488. doi: 10.1016/j.hfc.2022.02.005.
5
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e876-e894. doi: 10.1161/CIR.0000000000001062. Epub 2022 Apr 1.
6
Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes.转甲状腺素蛋白淀粉样心肌病患者晕厥:临床特征和结局。
Postgrad Med. 2022 May;134(4):420-428. doi: 10.1080/00325481.2022.2054174. Epub 2022 Mar 23.
7
Disease progression in cardiac morphology and function in heart failure: ATTR cardiac amyloidosis versus hypertensive left ventricular hypertrophy.心力衰竭中心脏形态和功能的疾病进展:ATTR 心脏淀粉样变性与高血压性左心室肥厚。
Heart Vessels. 2022 Sep;37(9):1562-1569. doi: 10.1007/s00380-022-02048-5. Epub 2022 Mar 11.
8
ATTR Amyloidosis: Current and Emerging Management Strategies: State-of-the-Art Review.转甲状腺素蛋白淀粉样变性:当前及新出现的管理策略:最新综述
JACC CardioOncol. 2021 Oct 19;3(4):488-505. doi: 10.1016/j.jaccao.2021.06.006. eCollection 2021 Oct.
9
Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator.心脏淀粉样变性患者与植入式心脏复律除颤器的治疗结果
Europace. 2020 Aug 1;22(8):1216-1223. doi: 10.1093/europace/euaa094.
10
Management of Arrhythmias in Cardiac Amyloidosis.心脏淀粉样变心律失常的处理。
JACC Clin Electrophysiol. 2020 Apr;6(4):351-361. doi: 10.1016/j.jacep.2020.01.004.